Molina Healthcare grants Zoretic trust 304 shares

Each director’s annual equity award was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter.

Rhea-AI Filing Summary

Molina Healthcare, Inc. reported a 304-share stock grant to the Richard Charles Zoretic Revocable Living Trust on October 1, 2026, in connection with director Richard C. Zoretic’s services under its 2025 Equity Incentive Plan. The trust held 9,693 shares after the grant, which reflected the issuer’s $180.85 closing price that day.

Insider Trade Summary

Grant/Award: 304 shares

Grant/Award 1 txn

Insider ZORETIC RICHARD C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2, F3, F4	304	$180.85	$55K

Holdings After Transaction: Common Stock — 9,693 shares (Indirect, Held by trust)

Footnotes (4)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
3. F3. Represents the closing price of the Issuer's common stock on October 1, 2026.
4. F4. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Key Figures

Stock grant: 304 shares Closing price: $180.85 per share Trust shares following grant: 9,693 shares +2 more

5 metrics

Stock grant 304 shares Granted October 1, 2026, to the Richard Charles Zoretic Revocable Living Trust

Closing price $180.85 per share Issuer’s common stock on October 1, 2026

Trust shares following grant 9,693 shares Reported holdings after the October 1, 2026 grant

Annual equity award $220,000 Award value set for each director

Quarterly equity award $55,000 One quarter of the annual award, to be granted on the first day of each quarter

Key Terms

2025 Equity Incentive Plan, annual equity award, closing price

3 terms

2025 Equity Incentive Plan financial

"under the Issuer's 2025 Equity Incentive Plan"

annual equity award financial

"the annual equity award to each director"

closing price financial

"based on the closing price of the Issuer's common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did the MOH director’s trust receive?

The Richard Charles Zoretic Revocable Living Trust received 304 shares on October 1, 2026, as a stock grant tied to Richard C. Zoretic’s director services; the trust’s reported holdings after the grant were 9,693 shares.

How are Molina Healthcare director equity awards scheduled?

The annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter based on the issuer’s common stock closing price on that day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:55 PM Accepted by SEC EDGAR 10/02/2026 - 04:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZORETIC RICHARD C

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A(1)		304(2)	A	$180.85(3)	9,693	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.

3. Represents the closing price of the Issuer's common stock on October 1, 2026.

4. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard C. Zoretic	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)